Although the conclusion needs more clinical studies to valid, PMEPA1 might has the potential to serve as a meaningful biomarker for high‐risk CRC or to serve as a therapeutic target for intervene colorectal cancer. This evidence concerns the gene PMEPA1 and colorectal cancer.